LENSAR Inc
- LNSR
- NASDAQ
- Medical devices
- Ophthalmic Laser Systems
- Cataract Surgery Technology
$5.75
Today −0.86%Quote Oct 19, 2026, 06:39 PM UTC
−18.19%over the last month
Max drawdown −20.0%From 1-month high −20.0%3 months +0.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About LENSAR
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally.
Where the money comes from
Q2 2026 revenue $16.5M
- Product$13.0M79.1%
- Service$1.7M10.2%
- Other / not reported$1.8M10.7%
Sector
Healthcare
Industry
Medical devices
Exchange
NASDAQ
Employees
150
Founded
2004
Market value
$70.6M
Quote Oct 19
Floor
$5.73
0.3% below price
Resistance
$5.82
1.2% above price
Price vs analyst targets
3 analysts
Lowest target
$11.00Highest target
$13.00
$11.00Highest target
$13.00
- Price $5.75
- Average target $12.00
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 109% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about LNSRPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free